![]() |
|
|
Vol. 304, Issue 1, 200-205, January 2003
Department of Pharmacology, University of Texas Health Science
Center, San Antonio, Texas
Coactivation of purinergic (P2Y) receptors reduces agonist
efficacy at serotonin1B (5-HT1B), but not
5-HT1A receptors. Herein, we report that pretreatment for 5 min with the P2Y receptor agonist ATP reduced agonist
responsiveness at the 5-HT1A, but not at the 5-HT1B, receptor. The effect of ATP pretreatment on the
5-HT1A receptor response rapidly reversed within a 10 min
time frame between P2Y receptor and 5-HT1A
receptor activation. ATP pretreatment effects on 5-HT1A
agonist responsiveness were blocked by the protein kinase inhibitors
staurosporine and bisindolylmaleimide, suggesting that the ATP-mediated
temporal regulation involves activation of protein kinase C (PKC).
Moreover, the temporal effect of ATP was blocked by incubation with 1%
ethanol, suggesting that consequences of phospholipase D (PLD)
activation play a role. ATP pretreatment blocked the inhibitory effect
produced by 5-HT2C receptor activation on the
5-HT1A, but not the 5-HT1B, receptor response,
suggesting that the 5-HT1A receptor itself was the target
for PLD/PKC action. Finally, ethanol did not block the reduction in
responsiveness of the 5-HT1A receptor system produced by
activation of PKC with phorbol ester treatment, suggesting that PKC
activation lies downstream of PLD. Taken together, these data suggest
that activation of P2Y receptors can reduce responsiveness
of the 5-HT1A receptor system via a PLD/PKC-dependent
mechanism that is highly dependent upon the temporal pattern of
receptor activation. Moreover, this work underscores the importance of
time as a variable in receptor signaling cross talk and serves to
further illustrate differences between the 5-HT1A and
5-HT1B receptor systems.
This article has been cited by other articles:
![]() |
A. M. Patwardhan, K. A. Berg, A. N. Akopain, N. A. Jeske, N. Gamper, W. P. Clarke, and K. M. Hargreaves Bradykinin-Induced Functional Competence and Trafficking of the {delta}-Opioid Receptor in Trigeminal Nociceptors J. Neurosci., September 28, 2005; 25(39): 8825 - 8832. [Abstract] [Full Text] [PDF] |
||||